Xiao-Xu-Ming decoction protects against blood-brain barrier disruption and neurological injury induced by cerebral ischemia and reperfusion in rats

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Lan, Rui ^a   Xiang, Jun ^a,b   Wang, Guo Hua ^a   Li, Wen Wei ^a   Zhang, Wen ^a   Xu, Li Li ^a   Cai, Ding Fang ^a  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EVANS BLUE; GELATINASE A; GELATINASE B; NEUROPROTECTIVE AGENT; UNCLASSIFIED DRUG; VASCULOTROPIN; XIAO XU MING;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; BRAIN PROTECTION; BRAIN WATER; CONTROLLED STUDY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE PERMEABILITY; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; REPERFUSION INJURY; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE; WESTERN BLOTTING;

EID: 84877948205     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/629782     Document Type: Article

References (42)

1. Del G. Z., Stroke and neurovascular protection. The New England Journal of Medicine 2006 354 6 553 555 2-s2.0-32144461723 10.1056/NEJMp058312 (Pubitemid 43209102)
2. Lo E. H., Dalkara T., Moskowitz M. A., Mechanisms, challenges and opportunities in stroke. Nature Reviews Neuroscience 2003 4 5 399 415 2-s2.0-0037868093 10.1038/nrn1106 (Pubitemid 37280178)
3. Lok J., Gupta P., Guo S., Kim W. J., Whalen M. J., Van Leyen K., Lo E. H., Cell-cell signaling in the neurovascular unit. Neurochemical Research 2007 32 12 2032 2045 2-s2.0-35848949798 10.1007/s11064-007-9342-9 (Pubitemid 350059847)
4. Ballabh P., Braun A., Nedergaard M., The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiology of Disease 2004 16 1 1 13 2-s2.0-2342471420 10.1016/j.nbd.2003.12.016 (Pubitemid 38569790)
5. Kuroiwa T., Ting P., Martinez H., Klatzo I., The biphasic opening of the blood-brain barrier to proteins following temporary middle cerebral artery occlusion. Acta Neuropathologica 1985 68 2 122 129 2-s2.0-0022410974 (Pubitemid 16242137)
6. Belayev L., Busto R., Zhao W., Ginsberg M. D., Quantitative evaluation of blood-brain barrier permeability following middle cerebral artery occlusion in rats. Brain Research 1996 739 1-2 88 96 2-s2.0-0030580410 10.1016/S0006-8993(96) 00815-3 (Pubitemid 26387366)
7. Rosenberg G. A., Matrix metalloproteinases and their multiple roles in neurodegenerative diseases. The Lancet Neurology 2009 8 2 205 216 2-s2.0-58249126857 10.1016/S1474-4422(09)70016-X
8. Lucivero V., Prontera M., Mezzapesa D. M., Petruzzellis M., Sancilio M., Tinelli A., Di Noia D., Ruggieri M., Federico F., Different roles of matrix metalloproteinases-2 and -9 after human ischaemic stroke. Neurological Sciences 2007 28 4 165 170 2-s2.0-34547959390 10.1007/s10072-007-0814-0 (Pubitemid 47263834)
9. Montaner J., Alvarez-Sabín J., Molina C. A., Anglés A., Abilleira S., Arenillas J., Monasterio J., Matrix metalloproteinase expression is related to hemorrhagic transformation after cardioembolic stroke. Stroke 2001 32 12 2762 2767 2-s2.0-0035207961 (Pubitemid 33134461)
10. Rosenberg G. A., Estrada E. Y., Dencoff J. E., Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. Stroke 1998 29 10 2189 2195 2-s2.0-0031693557 (Pubitemid 28443538)
11. Argaw A. T., Asp L., Zhang J., Navrazhina K., Pham T., Mariani J. N., Mahase S., Dutta D. J., Seto J., Kramer E. G., Ferrara N., Sofroniew M. V., John G. R., Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease. Journal of Clinical Investigation 2012 122 7 2454 2468 10.1172/JCI60842
12. Zhang Z. G., Zhang L., Jiang Q., Zhang R., Davies K., Powers C., Van Bruggen N., Chopp M., VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. Journal of Clinical Investigation 2000 106 7 829 838 2-s2.0-0033797255
13. Chiba Y., Miyake T. S. S., Koyama J., Kondoh T., Hosoda K., Kohmura E., Anti-VEGF receptor antagonist (VGA1155) reduces infarction in rat permanent focal brain ischemia. Kobe Journal of Medical Sciences 2008 54 2 E136 E146 2-s2.0-47849092865 (Pubitemid 352039825)
14. Chi O. Z., Hunter C., Liu X., Weiss H. R., Effects of anti-VEGF antibody on blood-brain barrier disruption in focal cerebral ischemia. Experimental Neurology 2007 204 1 283 287 2-s2.0-33847332493 10.1016/j.expneurol.2006.11.001 (Pubitemid 46330278)
15. Koyama J., Miyake S., Sasayama T., Chiba Y., Kondoh T., Kohmura E., The novel VEGF receptor antagonist, VGA1155, reduces edema, decreases infarct and improves neurological function after stroke in rats. Kobe Journal of Medical Sciences 2010 56 1 1 11 2-s2.0-77956621126
16. Du K., Wu C., Ding C., Zhao S., Qin H., Zhang J., Simultaneous LC-MS analysis and of wogonin and oroxylin a in rat plasma, and pharmacokinetic studies after administration of the active fraction from Xiao-Xu-Ming decoction. Chromatographia 2009 69 11-12 1259 1266 2-s2.0-67649992563 10.1365/s10337-009- 1072-5
17. Wang Y., Ding C., Du K., Xiao Y., Wu C., Zhang J., Qin H., Du G., Identification of active compounds and their metabolites by high-performance liquid chromatography/electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry from Xiao-Xu-Ming decoction (XXMD). Rapid Communications in Mass Spectrometry 2009 23 17 2724 2732 2-s2.0-69249126533 10.1002/rcm.4179
18. Li Z., Ni K., Du G., Simultaneous analysis of six effective components in the anti-Alzheimer's disease effective component group of Xiao-Xu-Ming decoction Chinese Journal of Chromatography 2007 25 1 80 83 2-s2.0-57149122998
19. Cai D. F., Yang Y. K., Gu X. X., Clinical trial on treatment of acute cerebral infarction with TCM treatment according to syndrome differentiation combining Western medicine by staging. Chinese Journal of Integrated Traditional and Western Medicine 2007 27 9 789 792 2-s2.0-58149180287
20. Shi X. M., Cai D. F., Dai W., Effect of QFTL TCP on endothelin and gene expression in acute cerebral ischemia. China Jounal of Modern Medicine 2003 13 5 6 9
21. Zhu X. H., Li S. J., Hu H. H., Sun L. R., Das M., Gao T. M., Neuroprotective effects of Xiao-Xu-Ming decoction against ischemic neuronal injury in vivo and in vitro. Journal of Ethnopharmacology 2010 127 1 38 46 2-s2.0-72149117930 10.1016/j.jep.2009.09.054
22. Longa E. Z., Weinstein P. R., Carlson S., Cummins R., Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989 20 1 84 91 2-s2.0-0024494427 (Pubitemid 19040218)
23. Bigdeli M. R., Hajizadeh S., Froozandeh M., Rasulian B., Heidarianpour A., Khoshbaten A., Prolonged and intermittent normobaric hyperoxia induce different degrees of ischemic tolerance in rat brain tissue. Brain Research 2007 1152 1 228 233 2-s2.0-34249069806 10.1016/j.brainres.2007.03.068 (Pubitemid 46802516)
24. Huang Z., Huang P. L., Panahian N., Dalkara T., Fishman M. C., Moskowitz M. A., Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science 1994 265 5180 1883 1885 2-s2.0-0027945658 (Pubitemid 24324247)
25. Li S.-Y., Yang D., Fu Z. J., Woo T., Wong D., Lo A. C. Y., Lutein enhances survival and reduces neuronal damage in a mouse model of ischemic stroke. Neurobiology of Disease 2012 45 1 624 632 10.1016/j.nbd.2011.10.008
26. Schallert T., Fleming S. M., Leasure J. L., Tillerson J. L., Bland S. T., CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury. Neuropharmacology 2000 39 5 777 787 2-s2.0-0033950675 10.1016/S0028-3908(00) 00005-8 (Pubitemid 30103682)
27. Zhao H., Shimohata T., Wang J. Q., Sun G., Schaal D. W., Sapolsky R. M., Steinberg G. K., Akt contributes to neuroprotection by hypothermia against cerebral ischemia in rats. Journal of Neuroscience 2005 25 42 9794 9806 2-s2.0-27144446140 10.1523/JNEUROSCI.3163-05.2005 (Pubitemid 41510919)
28. Gao X., Zhang H., Takahashi T., Hsieh J., Liao J., Steinberg G. K., Zhao H., The Akt signaling pathway contributes to postconditioning's protection against stroke; the protection is associated with the MAPK and PKC pathways. Journal of Neurochemistry 2008 105 3 943 955 2-s2.0-42449112592 10.1111/j.1471-4159.2008.05218.x (Pubitemid 351562746)
29. Borlongan C. V., Tajima Y., Trojanowski J. Q., Lee V. M. Y., Sanberg P. R., Transplantation of cryopreserved human embryonal carcinoma-derived neurons (NT2N cells) promotes functional recovery in ischemic rats. Experimental Neurology 1998 149 2 310 321 2-s2.0-0032006347 10.1006/exnr.1997.6730 (Pubitemid 28115069)
30. Hawkins B. T., Davis T. P., The blood-brain barrier/neurovascular unit in health and disease. Pharmacological Reviews 2005 57 2 173 185 2-s2.0-22944483792 10.1124/pr.57.2.4 (Pubitemid 41043883)
31. Ji H. H., Sang W. H., Lee S. K., Free radicals as triggers of brain edema formation after stroke. Free Radical Biology and Medicine 2005 39 1 51 70 2-s2.0-19544376509 10.1016/j.freeradbiomed.2005.03.035 (Pubitemid 40733116)
32. Liu J., Jin X., Liu K. J., Liu W., Matrix metalloproteinase-2-mediated occludin degradation and caveolin-1-mediated claudin-5 redistribution contribute to blood-brain barrier damage in early ischemic stroke stage. Journal of Neuroscience 2012 32 9 3044 3057 10.1523/JNEUROSCI.6409-11.2012
33. Yang Y., Rosenberg G. A., MMP-mediated disruption of claudin-5 in the blood-brain barrier of rat brain after cerebral ischemia. Methods in Molecular Biology 2011 762 333 345 2-s2.0-79960741978 10.1007/978-1-61779-185-7-24
34. Yang J. P., Liu H. J., Liu X. F., VEGF promotes angiogenesis and functional recovery in stroke rats. Journal of Investigative Surgery 2010 23 3 149 155 2-s2.0-77954233247 10.3109/08941930903469482
35. Wang Y. Q., Cui H. R., Yang S. Z., Sun H. P., Qiu M. H., Feng X. Y., Sun F. Y., VEGF enhance cortical newborn neurons and their neurite development in adult rat brain after cerebral ischemia. Neurochemistry International 2009 55 7 629 636 2-s2.0-69549127954 10.1016/j.neuint.2009.06.007
36. Li Z., Wang R., Li S., Wei J., Zhang Z., Li G., Dou W., Wei Y., Feng M., Intraventricular pre-treatment with rAAV-VEGF induces intracranial hypertension and aggravates ischemic injury at the early stage of transient focal cerebral ischemia in rats. Neurological Research 2008 30 8 868 875 2-s2.0-53549112176 10.1179/174313208X309720
37. Chi O. Z., Hunter C., Liu X., Weiss H. R., Effects of deferoxamine on blood-brain barrier disruption and VEGF in focal cerebral ischemia. Neurological Research 2008 30 3 288 293 2-s2.0-44449108066 10.1179/016164107X230135 (Pubitemid 351769424)
38. Wang W., Dentler W. L., Borchardt R. T., VEGF increases BMEC monolayer permeability by affecting occludin expression and tight junction assembly. The American Journal of Physiology 2001 280 1 H434 H440 2-s2.0-0035021651
39. Wang H., Keiser J. A., Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: role of flt-1. Circulation Research 1998 83 8 832 840 2-s2.0-0032547763 (Pubitemid 28489080)
40. Lamoreaux W. J., Fitzgerald M. E. C., Reiner A., Hasty K. A., Charles S. T., Vascular endothelial growth factor increases release of gelatinase A and decreases release of tissue inhibitor of metalloproteinases by microvascular endothelial cells in vitro. Microvascular Research 1998 55 1 29 42 2-s2.0-0031870786 10.1006/mvre.1997.2056 (Pubitemid 28368411)
41. Rooprai H. K., Rucklidge G. J., Panou C., Pilkington G. J., The effects of exogenous growth factors on matrix metalloproteinase secretion by human brain tumour cells. British Journal of Cancer 2000 82 1 52 55 2-s2.0-0033989425 (Pubitemid 30008958)
42. Valable S., Montaner J., Bellail A., Berezowski V., Brillault J., Cecchelli R., Divoux D., MacKenzie E. T., Bernaudin M., Roussel S., Petit E., VEGF-induced BBB permeability is associated with an MMP-9 activity increase in cerebral ischemia: both effects decreased by Ang-1. Journal of Cerebral Blood Flow and Metabolism 2005 25 11 1491 1504 2-s2.0-27544451238 10.1038/sj.jcbfm. 9600148 (Pubitemid 41541959)